Ritter Daniher Financial Advisory LLC DE Acquires 200 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Ritter Daniher Financial Advisory LLC DE boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 32.5% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 816 shares of the healthcare conglomerate’s stock after buying an additional 200 shares during the period. Ritter Daniher Financial Advisory LLC DE’s holdings in UnitedHealth Group were worth $411,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the business. Moneta Group Investment Advisors LLC boosted its holdings in shares of UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after purchasing an additional 11,812,017 shares during the last quarter. Norges Bank bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $5,210,004,000. Osaic Holdings Inc. boosted its holdings in shares of UnitedHealth Group by 776.9% during the 2nd quarter. Osaic Holdings Inc. now owns 3,248,409 shares of the healthcare conglomerate’s stock valued at $177,941,000 after purchasing an additional 2,877,983 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in shares of UnitedHealth Group by 1,682.4% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after purchasing an additional 2,540,538 shares during the last quarter. Finally, Bank of Montreal Can bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $1,087,367,000. Hedge funds and other institutional investors own 85.69% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of analyst reports. Morgan Stanley lowered their price target on shares of UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating for the company in a report on Monday, October 23rd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a report on Friday, January 19th. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. Royal Bank of Canada reissued an “outperform” rating and issued a $596.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, January 16th. Finally, UBS Group raised shares of UnitedHealth Group from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $520.00 to $640.00 in a research report on Monday, October 16th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $575.79.

Check Out Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Stock Down 0.4 %

NYSE:UNH traded down $1.87 during trading hours on Friday, reaching $518.22. The company’s stock had a trading volume of 2,715,493 shares, compared to its average volume of 4,824,929. The stock has a 50 day moving average price of $525.36 and a two-hundred day moving average price of $517.77. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.80 and a current ratio of 0.79. UnitedHealth Group Incorporated has a 12 month low of $445.68 and a 12 month high of $554.70. The company has a market capitalization of $479.31 billion, a P/E ratio of 21.74, a price-to-earnings-growth ratio of 1.41 and a beta of 0.54.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The business had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. During the same period in the previous year, the company earned $5.34 earnings per share. The business’s revenue for the quarter was up 14.1% on a year-over-year basis. Equities analysts predict that UnitedHealth Group Incorporated will post 27.84 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Stephen J. Hemsley sold 66,081 shares of the business’s stock in a transaction on Tuesday, December 5th. The shares were sold at an average price of $550.39, for a total transaction of $36,370,321.59. Following the sale, the director now directly owns 635,528 shares of the company’s stock, valued at $349,788,255.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.35% of the company’s stock.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.